| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.43 | 0.02 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.02 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |